BLOG

What Is Spravato? Spravato (esketamine) is an FDA-approved medication for treatment-resistant depression (TRD). Unlike traditional antidepressants, which primarily target serotonin, dopamine, and

ADHD (Attention-Deficit/Hyperactivity Disorder) can significantly impact adult relationships. Common symptoms like distractibility, forgetfulness, impulsivity, and emotional outbursts often lead to misunderstandings and

Seasonal Affective Disorder (SAD) affects millions of people, often during the darker winter months when exposure to natural sunlight is limited. Light

Ketamine-based therapies, including Spravato (esketamine) and intravenous (IV) ketamine, have revolutionized the treatment of treatment-resistant depression (TRD) and other mood disorders. These

Concentration is an essential cognitive function that allows us to focus on tasks, process information, and navigate daily life. However, difficulties with

Preparing for IV Ketamine or Spravato Treatment: A Comprehensive Guide For individuals with treatment-resistant depression (TRD) or severe depressive symptoms, IV ketamine

Spravato vs. IV Ketamine: Similarities and Differences in Treating Depression The landscape of depression treatment has been significantly broadened with the introduction